Defibrillators

Paul, Minnesota, plant between Nov.

9 and Dec.

7.

Guidant, which Boston Scientific acquired last year, had owned the facility, and the FDA had issued that company a warning letter about the deficiencies on Dec.

22, 2005.

"We are very pleased with the FDA's conclusion," Boston Scientific Chief Executive Jim Tobin said in a statement.

The FDA issued the warning letter for production and quality problems after Guidant recalled thousands of Boston Scientific acquired Guidant for $27 billion, winning a bidding war with Johnson & Johnson (JNJ.N: Quote, Profile, Research).

Continued...

End: Story Text © Reuters 2007.

All rights reserved.

Reuters Pictures Editors Choice: Best picturesfrom the last 24 hours.View Slideshow START News Content Page Tags 'Text' 'Video' ie.

articleId ie.

headline for article ie.

headline for article END News Content Page Tags end articleLeftUS articleText end articleContentsUS article Most Viewed Articles Adobe player frees viewers to watch video offline Nailgun injuries soar among weekend warriors Police gaffe makes Muslims pray in wrong direction Industry News ### Top Story Apple shareholders propose change to options dating 10:51am EDT Boston Scientific says plant problems resolved Spectrum gets FDA fast review; $4 mln payment More Industry Ne...

Read more...